🌐 EN ▾
  • EN - English
  • FR - French
  • DE - German
  • JP - Japanese
  • KR - Korean
Wellness Background
LIPOSOMAL GINKGO

Focus Unleashed with Liposomal Science

Ginkgo biloba - Nature's Cognitive Enhancer

Ginkgo biloba, often called a “living fossil,” is a time-honored botanical known for enhancing cognitive performance and circulation. Its leaf extract contains potent flavonol glycosides and terpene lactones that promote neuroprotection, memory retention, and cellular defense against oxidative stress.

Barriers to Bioavailability
Bioavailability Illustration

Low Solubility

Poor water solubility limits absorption.

First-Pass Metabolism

Rapid glucuronidation and sulfation reduce bioavailability.

Low Systemic Levels

Minimal circulating actives limit clinical impact.

The Liposomal Advantage

Liposomal Ginkgo biloba uses DFS Technology™ (Dietary Fiber Stabilized), an advanced liposomal delivery system designed to improve stability, absorption, and targeted delivery of bioactives. This cutting-edge phospholipid encapsulation protects Ginkgo's sensitive compounds during digestion, ensuring efficient uptake and sustained release for optimal brain and circulatory benefits.

Backed by Science, Proven in Research

Analytical Validation: Liposomal particles characterized by TEM imaging, Zeta Potential and PDI analysis, confirming uniform size distribution and stability.

Liposomal Ginkgo biloba Core Benefits

Memory

Enhances Memory &
Cognitive Clarity

Circulation

Supports Healthy
Blood Circulation

Neuro

Offers Neuroprotective &
Antioxidant Defense

Grade/Specification Available Form
Liposomal Ginkgo biloba 7% Powder

Why Liposomal Ginkgo biloba is Superior?

Feature
Liposomal Ginkgo biloba
Conventional Ginkgo biloba
Absorption Technology
DFS Technology™ - advanced liposomal delivery
Basic extract — limited absorption
Stability & Efficacy
Protected from degradation, sustained release
Easily degraded in GI tract
Analytical Validation
TEM, Zeta, PDI – advanced validation
Minimal or no validation
Tolerance
Gentle and effective delivery
May show delayed or reduced effects

Backed by External Peer-Reviewed Research

FRONTIERS | Frontiers in Neurology

STUDY YEAR | 2025 | YoungSoon Yang et al.

Efficacy of Ginkgo biloba extract in amyloid PET-positive patients with mild cognitive impairment. Ginkgo...

READ THE STUDY

KARGER | Dementia and Geriatric Cognitive Disorders

STUDY YEAR | 2024 | Debashish Chowdhury et al.

Multicenter, Open-Label, Prospective Study Shows Safety and Therapeutic Benefits of a Defined Ginkgo biloba extract...

READ THE STUDY

JOURNAL OF MEDICINE AND LIFE

STUDY YEAR | 2022 | Masoumeh Nazarinasab et al.

Investigating the efficacy of Ginkgo biloba on the cognitive function of patients undergoing treatment with electric shock...

READ THE STUDY

ELSEVIER | Complementary Therapies in Clinical Practice

STUDY YEAR | 2015 | Fereshteh Shakibaei et al.

Ginkgo biloba in the treatment of attention-deficit/hyperactivity disorder in children and adolescents...

READ THE STUDY

Š 2026 LipsoBioŽ All Rights Reserved.

Disclaimer -

top